ReviewApplied health economics and health policy2018
Individual and Institutional Corruption in European and US Healthcare: Overview and Link of Various Corruption Typologies.
Review in Applied health economics and health policy, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed.
- Investigating the relationship between corruption and health system outcomes in Central and Eastern Europe.European journal of public health · 2025Article
- Constricting Gaps: Protocol development, implementation challenges and lessons learned for theContemporary clinical trials communications · 2024Article
- Untangling the corruption maze: exploring the complexity of corruption in the health sector.Health economics review · 2024Review
- Determinants of life-expectancy and disability-adjusted life years (DALYs) in European and Organisation for Economic Co-operation and Development (OECD) countries: A longitudinal analysis (1990-2019).SSM - population health · 2023Article
- Socioecological factors linked with pharmaceutical incentive-driven prescribing in Pakistan.BMJ global health · 2023Article
- Does voluntary health insurance improve health and longevity? Evidence from European OECD countries.The European journal of health economics : HEPAC : health economics in prevention and care · 2022Article
- Editorial: Fraud and Corruption in Healthcare.Frontiers in public health · 2022Article
- Do Regulatory Changes Seriously Affect the Medical Devices Industry? Evidence From the Czech Republic.Frontiers in public health · 2021Article
- Pharmacy Internal Controls: A Call for Greater Vigilance during the COVID-19 Pandemic.Pharmacy (Basel, Switzerland) · 2020Review
- Anti-corruption, transparency and accountability in health: concepts, frameworks, and approaches.Global health action · 2020Review
- White paper: statement on conflicts of interest.Intensive care medicine · 2018Article
- Insights From Organized Crime for Disorganized Health Care.The Journal of ambulatory care managementArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In recent years, the fight against healthcare corruption has intensified. Estimates from the European Healthcare Fraud and Corruption Network calculate an approximate €56 billion annual loss to Europe as a result of corruption. To promote understanding of the complexity and interconnection of corrupt activities, we aim to present healthcare-related corruption typologies of the European Union and European Healthcare Fraud and Corruption Network. We subsequently link them to the typology of individual and institutional corruption introduced by Dennis Thompson in the context of investigating misconduct of US Congressional members. According to Thompson, individual corruption is the personal gain of individuals performing duties within an institution in exchange for nurturing private interests, while institutional corruption pertains to the failure of the institution in directing the individual's behaviour towards the achievement of the institution's primary purpose because the institutional design promotes the pursuit of individual goals. Effective anti-corruption activities not only require the enactment of anti-corruption laws but also the monitoring and, where appropriate, revision of institutional frameworks to prevent the undermining of the primary purposes of health systems or institutions. To gain further understanding of the similarities and differences of the three typologies, prime examples of corrupt activities in the health sector in the European Union and USA (along with their potential remedies) are provided. Linking corruption cases to Thompson's typology revealed that many corrupt activities may show elements of both individual and institutional corruption because they are intertwined, partly overlap and may occur jointly. Hence, sanctioning individual actors only does not target the problem.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.